Shanghai - Delayed Quote CNY

Lotus Health Group Company (600186.SS)

4.3200 +0.1300 (+3.10%)
At close: April 26 at 3:00 PM GMT+8
Key Events
Loading Chart for 600186.SS
DELL
  • Previous Close 4.1900
  • Open 4.1900
  • Bid 4.3100 x --
  • Ask 4.3200 x --
  • Day's Range 4.1900 - 4.3800
  • 52 Week Range 2.6600 - 8.2400
  • Volume 63,046,100
  • Avg. Volume 99,018,931
  • Market Cap (intraday) 7.75B
  • Beta (5Y Monthly) 0.37
  • PE Ratio (TTM) 72.00
  • EPS (TTM) 0.0600
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jul 11, 2002
  • 1y Target Est --

Lotus Health Group Company engages in the production and sale of condiments and foods in China. The company offers monosodium glutamate; chicken essence and other seasonings; and breadcrumbs and other flour products, as well as sauces, starch, and sugars. It also provides cooking wine and other liquid condiments, flour and pasta products, organic and water soluble fertilizers, sesame oil, brown sugar, gift packs, health packs, and baking soda. The company was formerly known as Lotus Health Industry Holding Group Company. Lotus Health Group Company was founded in 1983 and is based in Zhoukou, China.

www.mylotushealth.com

--

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 600186.SS

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

600186.SS
28.60%
SSE Composite Index
3.82%

1-Year Return

600186.SS
55.96%
SSE Composite Index
5.40%

3-Year Return

600186.SS
52.65%
SSE Composite Index
11.10%

5-Year Return

600186.SS
92.86%
SSE Composite Index
1.13%

Compare To: 600186.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 600186.SS

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    7.75B

  • Enterprise Value

    6.38B

  • Trailing P/E

    77.84

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.34

  • Price/Book (mrq)

    5.18

  • Enterprise Value/Revenue

    3.21

  • Enterprise Value/EBITDA

    51.54

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.07%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    10.45%

  • Revenue (ttm)

    2.1B

  • Net Income Avi to Common (ttm)

    127.62M

  • Diluted EPS (ttm)

    0.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.37B

  • Total Debt/Equity (mrq)

    0.05%

  • Levered Free Cash Flow (ttm)

    --

Company Insights: 600186.SS

People Also Watch